MDxHealth SA
EBR:MDXH.BR
3.02 (EUR) • At close December 15, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | MDxHealth SA |
Symbool | MDXH.BR |
Munteenheid | EUR |
Prijs | 3.02 |
Beurswaarde | 85,629,983 |
Dividendpercentage | 0% |
52-weken bereik | 1.975 - 6.9 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Michael K. McGarrity |
Website | https://mdxhealth.com |
An error occurred while fetching data.
Over MDxHealth SA
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)